A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)
Clinical trial NCT00273962 · COMPLETED
Trial details
- NCT number
- NCT00273962
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2003-11-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.